Few highly recurrent driver genes have been described in sarcomas with high genomic complexity [17], including defects in oncosuppressor genes RB1 and PTEN, mutations in TP53 and homozygous deletions of p16/CDKN2A, a cyclin-dependent kinase inhibitor [18, 19]. Here, CDKN2A is linked to sarcoma.